Today’s interconnected world and global economy means that increasing numbers of employees are required to travel extensively abroad, often for longer periods, to multiple destinations and often in very unfamiliar environments.

Engineers at the Institute of Bioengineering and Nanotechnology (IBN) , a member of the A*STAR’s group of biomedical sciences institutes in Singapore have developed a new material that claims to kill E. coli bacteria quickly and without the adverse health effects of triclosan, a common antibacterial agent that has been restricted in the European Union. IBN Group Leader Yugen Zhang, PhD, and his team, synthesized a chemical compound made

As we mentioned in our previous article¹ on how to mitigate corruption risks, in order for businesses to grow, companies and individuals need relationships with key influencers both within and outside the company. However, building relationships with influential individuals is very tricky.

Chris Mayo – Head of Global Services & Solutions, Non-North America,Willis Towers Watson Global Benefits Vision: Tell us about your career in Global Employee Benefits. Christopher Mayo: I have been involved with international employee benefits since 1990, when I was one of four people who set up the international practice at R. Watson & Sons. In 1995 I had the opportunity to work in Milan.